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To identify the active-site residues of the 3C proteinase of foot-and-mouth disease virus (FMDV), we introduced mutations
into the 3C coding region and examined the activity of mutant enzymes on various substrates. Based on alignment of FMDV
3C with other picornavirus 3C proteinases and with the trypsin family of serine proteinases, mutations were introduced at
residues presumed to be part of the catalytic triad, involved in substrate binding, or present in nonconserved regions. Wild-
type and mutant 3C proteins were expressed in Escherichia coli and tested for their ability to cleave synthetic substrates
corresponding to different portions of the viral genome. Substitutions at His-46 (catalytic triad), Asp-84 (catalytic triad), or
His-181 (substrate binding) produced enzymes unable to process P1, P2, or P3 substrates in trans, whereas a change in
the conserved Asp-98 had no effect on enzyme activity. Substitution of Ser for Cys-163 (catalytic triad) yielded an enzyme
that retained activity on some substrates, while a substitution of Gly at this position resulted in a completely inactive enzyme.
The kinetics of trans processing of translation products from a transcript encoding the P1 and P2 coding regions and the
2C/3A cleavage site with wild-type 3C or a transcript encoding P1 with 3C mutants revealed that the order of cleavage
was VP3-VP1, VP0-VP3, VP1-2A, 2C-3A, and 2B-2C. Mutations in 3C that resulted in a partially active enzyme were individually
introduced into full-length FMDV cDNA and RNA transcripts were translated in a cell-free system and used to transfect
cells. In all cases the virus that was rescued had reverted to the wild-type 3C codon. q 1995 Academic Press, Inc.
INTRODUCTION Ivanoff et al. (1986) constructed a clone containing the
complete 3C coding region and a portion of the 3D cod-
All picornaviral genomes are translated into a polypro-
ing region of poliovirus in an Escherichia coli expression
tein that is processed by a number of viral encoded pro-
system. Wild-type (WT) enzyme autocatalytically cleaved
teinases (Palmenberg, 1990). For foot-and-mouth dis- itself to produce the mature proteinase, while mutations
ease virus (FMDV) processing into the primary cleavage at the conserved Cys (Cys-147) and His (His-161) resi-
products leader (L), P1, P2, and P3 occurs cotransla- dues of 3C resulted in an inactive enzyme. In an exten-
tionally and is initiated by the L and 3C proteinases and sive computer analysis of viral and cellular proteinases,
the 2A oligopeptide. The initial processing event is the two groups independently suggested that the picornavi-
autocatalytic cleavage of L from P1 (Strebel and Beck, rus 3C enzymes are structurally and evolutionarily related
1986), followed by 2A cleavage between P1 and P2 at to the trypsin family of serine proteinases with the distinc-
the 2A/2B junction (Ryan et al., 1991). All other cleavages tion that the active-site nucleophile Ser has been re-
are catalyzed by 3C or a 3C containing precursor (Vak- placed by Cys (Cys-147; poliovirus numbering system) in
haria et al., 1987), except for the maturation cleavage of the viral enzymes (Bazan and Fletterick, 1988; Gorba-
VP0 in the provirion to generate the capsid proteins VP4 lenya et al., 1989). Both groups also identified His-40 of
and VP2. poliovirus 3C as the base component of the putative
Picornaviral 3C proteinases have been categorized as catalytic triad. However, Bazan and Fletterick (1988) pro-
thiol proteinases, since iodoacetamide and N-ethylmalei- posed that Asp-85 is the third component of the catalytic
mide inhibit their activity (Pelham, 1978), indicating that triad, whereas Gorbalenya et al. (1989) proposed that
Cys may be an active-site amino acid. A comparative Glu-71 performs this function. Support for this general
study of the derived amino acid sequences of these en- model was recently provided by the determination of the
zymes revealed a region of significant homology in the three-dimensional structure of rhinovirus and hepatitis A
carboxyl third of the protein, including conserved Cys and virus 3C (Mathews et al., 1994; Allaire et al., 1994).
His residues (Argos et al., 1984). Based on this analysis, In an attempt to characterize poliovirus and rhinovirus
3C, several groups have introduced mutations at specific
amino acid residues and examined the mutant proteins1 To whom correspondence and reprint requests should be ad-
for enzymatic activity (Baum et al., 1991; Cheah et al.,dressed. Fax: (516) 323-2507. E-mail: MGRUBMAN@ASRR.ARSUSDA.-
GOV. 1990; Cordingley et al., 1989; Hammerle et al., 1991, 1992;
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FIG. 1. Schematic representation of FMDV expression plasmids and construction of mutant 3C coding regions. The FMDV genome is shown in
A and includes the 5* and 3* untranslated regions (UTR, thick lines) and the complete coding region (boxed) (Rueckert and Wimmer, 1984). The
regions of the FMDV genome contained by the plasmids used to generate 3C substrates are indicated. B shows the individual mutations introduced
into the 3C coding region. All constructs are under the control of a T7 RNA polymerase promoter (j ); the vector sequence is represented
by thin lines.
Ivanoff et al., 1986; Kean et al., 1991, 1993; Lawson and contain 400 bases upstream of the L coding region start-
ing at nucleotide 716 and the L and P1 (VP0, VP3, andSemler, 1991). We have recently reported expression of
FMDV 3C in an E. coli system under the control of a VP1) coding regions. pTRP12 also contains the complete
P2 coding region and the first codon of the 3A sequence,bacteriophage T7 promoter and demonstrated biological
activity on in vitro synthesized P1 and P2 as substrates while pTRP1A contains the P2 coding region up to nucle-
otide 4295 of 2B. In addition, both plasmids contain 20(Bablanian and Grubman, 1993). Here we report the char-
acterization of a series of mutant 3C proteinases with codons from the vector pT7-7 (Tabor and Richardson,
1985) followed by an in-frame stop codon. Sequencingamino acid substitutions based on alignment with the
active-site residues of chymotrypsin. Activity of WT and of both pTRP12 and pP2 at the 2A/2B junction revealed
a difference from the published sequence at amino acidmutant enzymes was assayed on various in vitro synthe-
sized substrates. Mutations that resulted in enzymes with 16 of 2A, Arg to Gly (AGA to GGA), indicating that the
2A/2B cleavage is between Gly-Pro rather than Arg-Propartial processing activity were introduced into full-length
FMDV cDNA and RNA transcripts translated in vitro and (Robertson et al., 1985). Plasmid pRMC35 is a full-length
infectious clone of FMDV serotype A12 (Rieder et al.,transfected into susceptible cells.
1993) and pRM-LLV2 is a full-length clone lacking the L
(Lb) coding region (Piccone et al., 1995).MATERIALS AND METHODS
Plasmids
Site-directed mutagenesis
E. coli plasmids pTRP12, pTRP1A, pP2 (2A, 2B, and 2C
coding regions), and p3C (WT 3C coding region) were Mutant 3C coding regions were synthesized by overlap
extension PCR (Ho et al., 1989) using standard tech-described previously (Bablanian and Grubman, 1993;
Vakharia et al., 1987) (Fig. 1A). The first two plasmids niques. Each mutant coding region had a unique NdeI
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restriction site including an in-frame start codon (ATG) site, and NotI linearized plasmids pRM-3CD80E, pRM-
3CD84E, and pRM-3CC163S were synthesized with theat the 5* end and a termination codon (TAG) followed by
a Sal I restriction site at the 3* end. The mutated PCR T7 MEGAscript or T7 RiboMAX kits (Ambion and Pro-
mega, respectively). Approximately 0.5–1 mg of RNA fromproducts were digested with NdeI and Sal I and ligated
into NdeI, Sal I digested pT7-7 vector. Plasmids con- transcription reactions or 1 mg of FMD virion RNA was
used in a rabbit reticulocyte lysate in vitro translationtaining the mutant 3C coding regions were sequenced
through the amplified region by the dideoxy chain termi- system as previously described (Bablanian and Grub-
man, 1993; Grubman and Baxt, 1982; Vakharia et al.,nation method (Sanger et al., 1977) using Sequenase
Version 2.0 (U.S. Biochemicals). There were differences 1987).
in the WT and all mutant coding regions compared to
E. coli expression products and assay of enzymethe published sequence at residues 150, Ser to Gly (AGC
activityto GGC), and 196, Lys to Arg (AAG to AGG) (Robertson
et al., 1985). The differences were confirmed to be errors WT and mutant p3C plasmids were expressed in BL21
in the original sequence, since the original plasmid (DE3) cells and pellet fractions were prepared and stored
(pT268) was resequenced. Mutant 3C plasmids are des- at 0707 (Bablanian and Grubman, 1993). [35S]Methionine
ignated by the single-letter code for the WT amino acid in vitro translation products were mixed with an equal
followed by codon number and mutated amino acid (e.g., volume of 0.1 M unlabeled methionine and incubated
His at position 46 to Tyr is H46Y). overnight, or as indicated in the figure legend, at 307 with
1 volume of resuspended pellet fraction from induced
Construction of full-length cDNA clones with
BL21 (DE3) cells containing pT7-7, WT, or mutant p3C
mutations in the 3C gene
plasmids or unlabeled FMDV-infected or mock-infected
bovine kidney cell (LF-BK) postmitochondrial cytoplasmicTo facilitate construction of full-length cDNAs with ei-
extracts (S10). Products were analyzed by SDS–poly-ther the D80E or the D84E mutation, a unique NdeI site
acrylamide gel electrophoresis (SDS–PAGE). Thewas created in pRM-LLV2 in the 3C coding region up-
amount of E. coli WT and mutant 3C used in the cleavagestream of the mutations (pRM-LLV2/N). p3C-D80E and
assays was quantitated by SDS–PAGE and Coomassiep3C-D84E were amplified using a primer containing the
blue staining (Bablanian and Grubman, 1993) and essen-unique NdeI site and a second primer at the 3* end of
tially equivalent amounts of all E. coli expressed enzymesthe 3C coding region, inserted into pCR (Invitrogen), and
were used.the amplified regions completely sequenced. These lat-
ter plasmids were digested with NdeI and EcoRV (unique
Transfection and characterization of 3C mutantsite downstream of codon 84) and inserted into similarly
virusesdigested pRM-LLV2/N. The clones were digested to re-
move the appropriate fragment and this fragment was RNA transcripts were transfected into baby hamster
inserted into similarly digested pRMC35 . The full-length kidney cells (BHK-21) using Lipofectin or electroporation
clones, pRM-3CD80E and pRM-3CD84E, were checked (Rieder et al., 1993; Mason et al., 1994). After electropora-
by restriction enzyme analysis and sequenced through tion, cells were radiolabeled with [35S]methionine and
the inserted mutation. examined for virus assembly and viral protein synthesis.
To construct a full-length cDNA containing the C163S Supernatants from cells transfected by either procedure
mutation, a region encompassing codon 163 was ampli- (Pass 1) were used to produce virus stocks. RNA ex-
fied by overlap extension PCR to contain the Ser-163 tracted from Pass 2 or Pass 3 virus was used as a tem-
mutation, inserted into a subgenomic clone, and the am- plate for cDNA synthesis with Moloney murine leukemia
plified region was completely sequenced. The subgeno- virus reverse transcriptase (Superscript, Gibco BRL) and
mic clone was digested with restriction enzymes that cut random hexamers. The cDNA corresponding to the 3C
at unique sites in the genome surrounding codon 163 coding region was amplified with the appropriate primers
and the appropriate fragment inserted into similarly di- by PCR and the PCR products were directly sequenced
gested pRMC35 . The full-length cDNA containing the 3C with the Sequenase PCR Product Sequencing kit (USB/
mutation, pRM-3CC163S, was checked as above. Amersham).
In vitro transcription and translation
RESULTS
Transcripts from Sal I linearized plasmid pP2 were syn- Construction of 3C mutants
thesized using T7 RNA polymerase and the mMESSAGE,
mMACHINE capping kit (Ambion). Transcripts from Mutations were introduced individually at amino acid
residues 46(H46Y), 73(E73Q), 80(D80E), 84(D84E andEcoRV linearized plasmids pTRP1A and pTRP12, which
contain the majority of the FMDV internal ribosome entry D84N), 98(D98N), 163(C163S and C163G), and 181(H181Y)
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mock-infected LF-BK cells had no effect on the substrate
(data not shown; Bablanian and Grubman, 1993). Substi-
tutions at residues 46 (H46Y) and 181 (H181Y) completely
eliminated 3C activity (lanes 4 and 12), while mutants
E73Q, D98N, and H205R showed WT cleavage activity
(lanes 5, 9, and data not shown). Mutants D80E, D84E,
and C163S had almost WT activity on P1-2A, but did not
process the VP1/2A cleavage site efficiently (lanes 6, 7,
and 10). If Asp-84 was mutated to Asn (D84N) only the
VP3/VP1 site was cleaved (lane 8). Mutation of Cys-163
to Gly (C163G) resulted in a completely inactive enzyme
(lane 11).
Activity of 3C mutants on P2 substrates
Transcripts synthesized from Sal I linearized pP2 (Fig.
1A) with T7 RNA polymerase were translated in a cell-
free system and radiolabeled translation products incu-
bated with the various lysates from induced E. coli (Fig.
FIG. 2. Processing of radiolabeled translation products from pTRP1A 3). WT and mutants E73Q, D98N, and H205R completely
transcripts by WT and mutant 3C proteinases expressed in E. coli. processed P2 into 2C, 2A-2B, and 2B (lanes 3, 5, 9, and
[35S]Methionine-labeled translation products synthesized from pTRP1A
data not shown), while 3C mutants H46Y, D84N, C163G,transcripts were mixed with the pellet fraction of lysates from trans-
and H181Y were completely inactive (lanes 4, 8, 11, andformed E. coli expressing WT or mutant 3C proteinases, incubated
overnight at 307, and analyzed by SDS–PAGE on a 15% gel. Lanes 2– 12). Mutants D80E, D84E, and C163S retained approxi-
12, translation products mixed with pT7-7, WT, H46Y, E73Q, D80E, mately 5–10% WT activity on P2 as measured by the
D84E, D84N, D98N, C163S, C163G, and H181Y lysates, respectively; presence of 2C (lanes 6, 7, and 10). The kinetics of pro-
lane M, cell-free translation programmed with FMD virion RNA as
marker.
in the 3C coding region by overlap extension PCR. The
mutant coding regions were cloned into the vector pT7-
7 and transformed into HB101 cells. Plasmids containing
the 3C coding region with the expected mutation were
transformed into BL21 (DE3) cells, induced with IPTG,
treated with rifampicin, and radiolabeled with [35S]-
methionine. All the mutant 3C proteins comigrated with
the WT 3C and as determined by Coomassie blue stain-
ing each comprised about 5% of the total cell protein
(data not shown). An additional mutant derived during
construction of WT 3C had a change at amino acid resi-
due 205 (H205R) and was also utilized in the following
studies. Figure 1B shows the position of the mutations
introduced in the 3C coding region.
Activity of 3C mutants on P1 substrate
To examine the effect of different mutations in 3C on
processing of P1, radiolabeled substrate derived from
FIG. 3. Processing of radiolabeled translation products from pP2
translation of pTRP1A (Fig. 1A) was incubated with unla- transcripts by WT and mutant 3C proteinases expressed in E. coli.
beled lysates from induced E. coli cells containing the [35S]Methionine-labeled translation products synthesized from pP2
transcripts were mixed with the pellet fraction of lysates from trans-vector pT7-7, WT 3C, and each of the 3C mutants. A
formed E. coli expressing WT or mutant 3C proteinases, incubatedlysate from induced cells containing pT7-7 had no effect
overnight at 307, and analyzed by SDS–PAGE on a 15% gel. Lanes 2–on P1-2A, whereas WT 3C completely processed P1-2A
12, translation products mixed with pT7-7, WT, H46Y, E73Q, D80E,
into structural proteins VP0, VP3, and VP1 (Fig. 2, lanes D84E, D84N, D98N, C163S, C163G, and H181Y lysates, respectively;
2 and 3). An S10 extract from FMDV-infected LF-BK cells lane M, cell-free translation programmed with FMD virion RNA as
marker.also completely processed P1-2A, while an extract from
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cessing of P2 by WT 3C revealed that 2A-2B and 2B
appeared at the same time and in the same ratio as after
an overnight incubation (data not shown).
Activity of 3C mutants on P1, P2, and 2C-3A
substrates
Plasmid pTRP12 (Fig. 1A) provides a source of P1 and
P2 substrates as well as the 2C/3A cleavage site. Trans-
lation of transcripts from pTRP12 resulted in synthesis
of P1-2A and P2-3A*. Protein P2-3A* migrates slightly
slower than P2, since it contains the first amino acid of
3A (isoleucine) and 20 amino acids from the vector before
an in-frame stop codon. WT 3C and mutants E73Q, D98N,
and H205R completely processed the substrates, at all
3C cleavage sites, into VP0, VP3, VP1, 2C, and 2B (Fig.
4, lanes 3, 5, 9, and data not shown), whereas mutants
H46Y, C163G, and H181Y were completely inactive on
all P1-2A, P2, and 2C/3A cleavage sites (lanes 4, 11, and
12). Mutant D84N partially processed the 2C/3A and VP3/
FIG. 5. Kinetics of processing of radiolabeled translation productsVP1 sites, but was inactive at all other sites (lane 8).
from pTRP12 transcripts by WT 3C proteinase expressed in E. coli.Mutants D80E, D84E, and C163S had partial activity on
[35S]Methionine-labeled translation products from pTRP12 transcriptsP1-2A and at the 2C/3A cleavage site to produce P2, but,
were incubated for varying periods of time at 307 with the pellet fraction
as shown previously, did not efficiently cleave at the VP1/ of a lysate from transformed E. coli expressing WT 3C proteinase and
2A cleavage site or within P2 (lanes 6, 7, and 10). analyzed by SDS–PAGE on a 15% gel. Lanes 2–9, translation products
mixed with WT 3C and incubated for 0, 5, 15, 30, 60, 120, and 240 min
and overnight, respectively; lane M, cell-free translation programmed
with FMD virion RNA as marker. The major band immediately above
VP0 in lanes 2–9 is an endogenous reticulocyte protein.
Order of processing of P1, P2, and 2C/3A substrates
To determine the order of processing of primary prod-
ucts P1, P2, and at the 2C/3A cleavage site, translation
products from pTRP12 transcripts were incubated for var-
ying periods of time with WT 3C (Fig. 5). Within 5 min of
addition of WT 3C to the translation products, P1-2A is
almost completely processed to VP0, VP3, and VP1 (lane
3). Some VP1-2A is still present at 5 min, but is completely
processed by 15–30 min (lanes 4 and 5). Processing of
P1-2A is just as rapid when incubation is at 257 (data not
shown). Processing at the 2C/3A site starts within 5 min,
as demonstrated by the decrease in amount of P2-3A*
and the appearance of P2, and is essentially complete
by 60 min (lanes 3–6). The amount of P2 increases until
about 60 min and decreases with longer incubation
FIG. 4. Processing of radiolabeled translation products from pTRP12 (lanes 3–9). 2C and 2B do not appear until about 30–60
transcripts by WT and mutant 3C proteinases expressed in E. coli.
min (lanes 5 and 6) and the amount of these two proteins[35S]Methionine-labeled translation products from pTRP12 transcripts
increases with time (lanes 5–9).were mixed with the pellet fraction of lysates from transformed E. coli
expressing WT or mutant 3C proteinases, incubated overnight at 307, Addition of 3C mutants D84E or C163S to translation
and analyzed by SDS–PAGE on a 15% gel. Lanes 2–12, translation products of pTRP1A resulted in processing of P1-2A, but
products mixed with pT7-7, WT, H46Y, E73Q, D80E, D84E, D84N, D98N, at a reduced rate as compared to processing by WT 3C
C163S, C163G, and H181Y lysates, respectively; lane M, cell-free trans-
(data not shown). The initial processing event occurredlation programmed with FMD virion RNA as marker. The major band
at the VP3/VP1 cleavage site, resulting in the appearanceimmediately above VP0 in lanes 2–12 is an endogenous reticulocyte
protein. of VP0-VP3 and VP1-2A. Mutant D84E processed the
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FIG. 6. In vitro translation of full-length 3C mutant transcripts pRM-3CD80E (A), pRM-3CD84E (B), and pRM-3CC163S (C). The above transcripts
were translated for 2 hr, 4 hr, 6 hr, or overnight (lanes 1–4, respectively) and analyzed by SDS–PAGE on a 15% gel. Lane M in A is a cell-free
translation programmed with FMD virion RNA as marker.
VP0/VP3 and VP1/2A cleavage sites much more rapidly was extremely inefficient. We were not able to follow
the order of processing within P3 (data not shown).than C163S.
Translation reactions from pRM-3CD80E derived tran-
scripts contained P3, P1-2A, and L, but only smallEffect of mutant 3C proteins on viral replication
amounts of P2 were present (Fig. 6A). In addition, there
Since mutations at residues 80 (D80E), 84 (D84E), and were small amounts of two high-molecular-weight pro-
163 (C163S) resulted in enzymes with partial cleavage teins (indicated by an open arrowhead), as well as a
activity, we individually introduced these mutations into major protein migrating slightly faster than P1-2A (P2-
a genome-length cDNA clone to determine their effect P3*). Immunoprecipitation of the 4-hr translation prod-
on viral replication. In vitro translation of transcripts de- ucts of pRM-3CD80E transcripts indicated that P2-P3*
rived from the three mutant clones revealed that there contained 2B, 2C, and 3C (data not shown). Further-
was only partial protein processing as compared to more, the translation products were correctly processed
translation of WT RNA (Fig. 6). Primary cleavage prod- by E. coli expressed WT 3C (not shown).
ucts P3, P1-2A, P2, and L were present in the translation Transcripts derived from the three full-length mutant
of transcripts pRM-3CD84E and pRM-3CC163S (Figs. cDNA clones were transfected into BHK-21 cells by
6B and 6C, lane 1), but the 3C catalyzed secondary Lipofectin, but no plaques were detected by plaque
cleavages to yield mature structural and nonstructural assay. To examine for the presence of viral protein
proteins did not occur. In addition, a larger protein (indi- synthesis in transfected cells, we used electropora-
cated by an arrowhead), which was immunoprecipitated tion, which we have previously shown to be a highly
with sera specific for P2 or P3 polypeptides (data not efficient method of transfection (Mason et al., 1994).
shown), was present. Longer incubation of the pRM- Examination of radiolabeled culture fluids and cell ly-
3CD84E and pRM-3CC163S translation reactions sates showed that viral protein synthesis did not occur.
showed that the mutant 3C could gradually process the The supernatants from transfected cells were used to
primary products as well as the larger precursor to VP0, infect BHK cells and plaque-forming virus was ob-
VP1-2A, VP3, VP1, and less efficiently to 3D, 2C, and 2B tained with the three different mutant full-length cDNA
(Figs. 6B and 6C, lanes 2 – 4). In both cases processing clones. RNA extracted from second- and third-passage
was also examined by addition of WT E. coli expressed virus stocks was used as a template for reverse tran-
3C to the 2-hr translation products. Processing within scriptase – PCR and in all cases the mutant codons had
reverted to the WT codon.P1-2A was rapid, while processing within P2 and P3
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TABLE 1
Characterization of 3C Mutants
Processing
Mutants Codon change P1a P2a 2C-3A* a Virus recovery
Wild type //// //// //// Yes
H46Y CAT r TAT 0 0 0 NDb
E73Q GAG r CAG //// //// //// ND
D80E GAC r GAG /// / /// Reverted
D84E GAC r GAA /// / /// Reverted
D84N GAC r AAC //0 0 / ND
D98N GAT r AAT //// //// //// ND
C163S TGT r AGT /// / //// Reverted
C163G TGT r GGT 0 0 0 ND
H181Y CAC r TAC 0 0 0 ND
H205R CAC r CGC //// //// //// ND
a Each assay represents the average of at least three independent experiments (////, WT activity; 0, no activity).
b Not determined; this mutation was not transferred to a full-length cDNA.
DISCUSSION conserved among picornavirus 3C enzymes. Mutation at
Glu-73, proposed by Gorbalenya et al. (1989) to be part
To identify amino acid residues which are important
of the loop connecting b-strands E and F to Gln (E73Q),
in FMDV 3C proteinase activity, we characterized the
has no effect on enzyme activity. However, a change in
activity of a series of single-site mutants. The residues
Asp-80, also predicted to be part of the loop connectingchosen for modification were based on the models of
b-strands E and F, but closer to b-strand F, to Glu (D80E),Bazan and Fletterick (1988) and Gorbalenya et al. (1989),
results in an enzyme that has reduced activity at the VP1/which suggested that the picornavirus 3C enzymes are
2A and 2C/3A sites and significantly reduced activity atstructurally and evolutionarily related to the trypsin family
the 2B/2C site. Mutant H205R, which has an alterationof serine proteinases. The WT and mutant enzymes ex-
in a residue present in an a-helix region close to the C-pressed in E. coli were assayed for trans cleavage activ-
terminus of the protein, was indistinguishable from WTity on a number of in vitro radiolabeled substrates gener-
in all cleavage assays examined.ated from transcripts representing different portions of
We found that substitution of Ser for the Cys residuethe genome. Our results agree with the general model
(C163S), proposed to be the catalytic nucleophile, didproposed by both groups and recently supported utilizing
not result in a completely inactive enzyme. Instead thisa similar mutagenesis strategy for poliovirus and rhinovi-
enzyme retained activity on some of the substrates as-rus 3C (Cheah et al., 1990; Hammerle et al., 1991, 1992;
sayed. These results are in agreement with those of Law-Kean et al., 1991, 1993; Lawson and Semler, 1991).
son and Semler (1991) and Kean et al. (1993) for poliovi-In both models, FMDV 3C residues His-46 and Cys-
rus 3C proteinase. The FMDV 3C C163S mutant retained163 (equivalent to poliovirus 3C His-40 and Cys-147, re-
activity on the structural protein precursor P1-2A, al-spectively) are implicated as part of the catalytic triad
though the rate of cleavage was significantly reduced.and His-181 (equivalent to poliovirus His-161) as part of
The mutant completely processed the 2C/3A site, butthe binding pocket. Our results support the essential role
showed minimal activity at the 2B/2C cleavage site. Inof these residues in the function of 3C (Table 1). The
contrast, the equivalent poliovirus 3C mutant (C147S)models differ as to the third member of the catalytic
showed minimal activity on P1, but displayed WT activitytriad. Our data support the prediction of Gorbalenya et
on P2. Presumably, as suggested by Lawson and Semleral. (1989), since mutation of Asp-84 to Asn (D84N) results
(1991), the ability of the C163S mutant to retain partialin an almost inactive enzyme, whereas the same muta-
trans proteolytic activity may be explained by the ability oftion at Asp-98 (D98N) has essentially no effect on trans
the Ser hydroxyl group to substitute for the Cys sulfhydrylcleavage activity. Additional support for this model was
group as a nucleophile. In support of this, substitution ofrecently provided by determination of the X-ray crystal
Gly for Cys-163 (C163G) in FMDV 3C or Ala for Cys-147structure of the rhinovirus 3C proteinase (Mathews et al.,
in poliovirus 3C resulted in a completely inactive enzyme1994). However, the X-ray crystal structure of the hepatitis
(Figs. 2–4; Lawson and Semler, 1991).A virus 3C suggests that the active site is only a dyad
Addition of E. coli expressed WT 3C to a system con-of Cys/His residues (Allaire et al., 1994).
We made additional mutations at residues that are not taining P1-2A and P2 precursors demonstrated that pro-
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in gene organization and homology between proteins of animal picor-cessing of P1-2A was essentially complete prior to cleav-
naviruses and a plant comovirus suggest common ancestry of theseage within P2. Processing of P2 synthesized from pTRP12
virus families. Nucleic Acids Res. 12, 7251–7267.
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